抗癌药-话题@MedSci

#抗癌药#

351篇内容 | 5645人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1314626, encodeId=4bcb131462660, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=卫材新型抗癌药Lenvima获日本批准，将成为甲状腺癌临床治疗新标准, objectType=article, longId=48685, objectId=bdbd4868512, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdbd4868512, replyNumber=0, likeNumber=68, createdTime=2015-03-29, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdbd4868512, moduleTitle=卫材新型抗癌药Lenvima获日本批准，将成为甲状腺癌临床治疗新标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdbd4868512)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314625, encodeId=4ed01314625ad, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=Chemistry & Biology ：靶向Exportin-1的新型抗癌药, objectType=article, longId=47849, objectId=aea74e849ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aea74e849ff, replyNumber=0, likeNumber=58, createdTime=2015-03-08, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aea74e849ff, moduleTitle=Chemistry & Biology ：靶向Exportin-1的新型抗癌药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aea74e849ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314624, encodeId=10dd13146246d, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=抗癌药研发四大里程碑各有哪些挑战?, objectType=article, longId=47604, objectId=b5744e604b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5744e604b0, replyNumber=0, likeNumber=75, createdTime=2015-03-04, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5744e604b0, moduleTitle=抗癌药研发四大里程碑各有哪些挑战?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5744e604b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314623, encodeId=3eac131462399, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=重磅！诺华抗癌药Farydak获FDA批准，系治疗多发性骨髓瘤的HDAC抑制剂, objectType=article, longId=47498, objectId=7e584e4988f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e584e4988f, replyNumber=0, likeNumber=72, createdTime=2015-03-01, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e584e4988f, moduleTitle=重磅！诺华抗癌药Farydak获FDA批准，系治疗多发性骨髓瘤的HDAC抑制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e584e4988f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314622, encodeId=03191314622bd, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=抗生素还是抗癌药？Pharmacyclics温馨提示, objectType=article, longId=47495, objectId=fb064e49519, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb064e49519, replyNumber=0, likeNumber=72, createdTime=2015-03-01, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb064e49519, moduleTitle=抗生素还是抗癌药？Pharmacyclics温馨提示, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb064e49519)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314621, encodeId=9e551314621a7, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=进口抗癌药格列卫成天价特殊环境催高药价, objectType=article, longId=45406, objectId=a19b4540688, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a19b4540688, replyNumber=0, likeNumber=50, createdTime=2015-01-15, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a19b4540688, moduleTitle=进口抗癌药格列卫成天价特殊环境催高药价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a19b4540688)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314620, encodeId=78421314620ed, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=抗癌药物研发：在失败中涅槃, objectType=article, longId=44577, objectId=d907445e7b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d907445e7b7, replyNumber=0, likeNumber=67, createdTime=2014-12-26, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d907445e7b7, moduleTitle=抗癌药物研发：在失败中涅槃, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d907445e7b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314619, encodeId=19e9131461953, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=Bind抗癌药物BIND-014二期研究数据喜忧参半, objectType=article, longId=42961, objectId=4338429617e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4338429617e, replyNumber=0, likeNumber=68, createdTime=2014-11-23, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4338429617e, moduleTitle=Bind抗癌药物BIND-014二期研究数据喜忧参半, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4338429617e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314618, encodeId=1f48131461849, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=Mol Can Therap：实验性抗癌药物TAK-733或是新一代杀灭黑色素瘤的利器, objectType=article, longId=42645, objectId=aaf742645e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aaf742645e0, replyNumber=0, likeNumber=63, createdTime=2014-11-19, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aaf742645e0, moduleTitle=Mol Can Therap：实验性抗癌药物TAK-733或是新一代杀灭黑色素瘤的利器, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aaf742645e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314617, encodeId=9074131461e36, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=勃林格启动抗癌药nintedanib结直肠癌全球III期研究, objectType=article, longId=41705, objectId=0fbd41e05ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fbd41e05ec, replyNumber=0, likeNumber=55, createdTime=2014-10-26, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fbd41e05ec, moduleTitle=勃林格启动抗癌药nintedanib结直肠癌全球III期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0fbd41e05ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314616, encodeId=fa44131461699, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=Cancer Cell：旧研究，新方法，新型抗癌药物无任何毒副作用！, objectType=article, longId=41329, objectId=9360413293b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9360413293b, replyNumber=0, likeNumber=74, createdTime=2014-10-18, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9360413293b, moduleTitle=Cancer Cell：旧研究，新方法，新型抗癌药物无任何毒副作用！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9360413293b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314615, encodeId=38921314615b9, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=PhRMA：在研771种抗癌药物报告, objectType=article, longId=41238, objectId=432941238d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=432941238d0, replyNumber=0, likeNumber=78, createdTime=2014-10-16, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=432941238d0, moduleTitle=PhRMA：在研771种抗癌药物报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=432941238d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314614, encodeId=3da3131461434, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=克雪兰诺、ICR与Wellcome Trust合作开发新型抗癌药物, objectType=article, longId=41018, objectId=30fa41018b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30fa41018b5, replyNumber=0, likeNumber=56, createdTime=2014-10-11, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30fa41018b5, moduleTitle=克雪兰诺、ICR与Wellcome Trust合作开发新型抗癌药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30fa41018b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314613, encodeId=6720131461366, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=是好药总会出彩---段雪藏10年的抗癌药研发历程, objectType=article, longId=39858, objectId=a13c39858a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a13c39858a0, replyNumber=0, likeNumber=0, createdTime=2014-09-04, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a13c39858a0, moduleTitle=是好药总会出彩---段雪藏10年的抗癌药研发历程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a13c39858a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314612, encodeId=8dd81314612bc, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=卫材抗癌药Halaven III期非小细胞肺癌失败（Study 302试验）, objectType=article, longId=38937, objectId=6acd3893ee2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6acd3893ee2, replyNumber=0, likeNumber=66, createdTime=2014-08-13, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6acd3893ee2, moduleTitle=卫材抗癌药Halaven III期非小细胞肺癌失败（Study 302试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6acd3893ee2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314611, encodeId=c6ae13146117e, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=AIDS 2014：抗癌药能激活休眠HIV病毒, objectType=article, longId=38194, objectId=1d8f381941c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d8f381941c, replyNumber=0, likeNumber=64, createdTime=2014-07-26, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d8f381941c, moduleTitle=AIDS 2014：抗癌药能激活休眠HIV病毒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d8f381941c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314610, encodeId=8aca13146105c, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=CHMP支持批准拜耳抗癌药Stivarga用于GIST的治疗, objectType=article, longId=37289, objectId=c6183e28946, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6183e28946, replyNumber=0, likeNumber=106, createdTime=2014-07-04, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6183e28946, moduleTitle=CHMP支持批准拜耳抗癌药Stivarga用于GIST的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6183e28946)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314609, encodeId=b5f01314609f7, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=阿斯利康“死去”的抗癌药物Olaparib“复活”, objectType=article, longId=37141, objectId=ef013e1416c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef013e1416c, replyNumber=0, likeNumber=61, createdTime=2014-06-29, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef013e1416c, moduleTitle=阿斯利康“死去”的抗癌药物Olaparib“复活”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef013e1416c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314607, encodeId=56e7131460e5c, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=恒瑞医药抗癌药奥沙利铂通过FDA认证, objectType=article, longId=37012, objectId=f9493e01253, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9493e01253, replyNumber=0, likeNumber=87, createdTime=2014-06-27, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9493e01253, moduleTitle=恒瑞医药抗癌药奥沙利铂通过FDA认证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9493e01253)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1314608, encodeId=0b161314608f3, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, objectTitle=阿斯利康抗癌药olaparib上市之路坎坷不平, objectType=article, longId=37015, objectId=47733e0152d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47733e0152d, replyNumber=0, likeNumber=56, createdTime=2014-06-27, rootId=0, userName=sunylz, userId=12de429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47733e0152d, moduleTitle=阿斯利康抗癌药olaparib上市之路坎坷不平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47733e0152d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗癌药

2020-05-29

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

卫材新型抗癌药Lenvima获日本批准，将成为甲状腺癌临床治疗新标准

2015-03-29

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

Chemistry & Biology ：靶向Exportin-1的新型抗癌药

2015-03-08

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

抗癌药研发四大里程碑各有哪些挑战?

2015-03-04

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

重磅！诺华抗癌药Farydak获FDA批准，系治疗多发性骨髓瘤的HDAC抑制剂

2015-03-01

爆笑小医 (审核中...)

前往app查看评论内容

#抗癌药#

抗生素还是抗癌药？Pharmacyclics温馨提示

2015-03-01

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

进口抗癌药格列卫成天价特殊环境催高药价

2015-01-15

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

抗癌药物研发：在失败中涅槃

2014-12-26

docwu2019 (审核中...)

前往app查看评论内容

#抗癌药#

Bind抗癌药物BIND-014二期研究数据喜忧参半

2014-11-23

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

Mol Can Therap：实验性抗癌药物TAK-733或是新一代杀灭黑色素瘤的利器

2014-11-19

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

勃林格启动抗癌药nintedanib结直肠癌全球III期研究

2014-10-26

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

Cancer Cell：旧研究，新方法，新型抗癌药物无任何毒副作用！

2014-10-18

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

PhRMA：在研771种抗癌药物报告

2014-10-16

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

克雪兰诺、ICR与Wellcome Trust合作开发新型抗癌药物

2014-10-11

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

是好药总会出彩---段雪藏10年的抗癌药研发历程

2014-09-04

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

卫材抗癌药Halaven III期非小细胞肺癌失败（Study 302试验）

2014-08-13

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

AIDS 2014：抗癌药能激活休眠HIV病毒

2014-07-26

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

CHMP支持批准拜耳抗癌药Stivarga用于GIST的治疗

2014-07-04

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

阿斯利康“死去”的抗癌药物Olaparib“复活”

2014-06-29

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

恒瑞医药抗癌药奥沙利铂通过FDA认证

2014-06-27

sunylz (审核中...)

前往app查看评论内容

#抗癌药#

阿斯利康抗癌药olaparib上市之路坎坷不平

2014-06-27

科室
- - 订阅+
  - 更多科室
工具
服务